Singh, M.; Negi, R.; Alka; Vinayagam, R.; Kang, S.G.; Shukla, P.
Age-Related Macular Degeneration (AMD): Pathophysiology, Drug Targeting Approaches, and Recent Developments in Nanotherapeutics. Medicina 2024, 60, 1647.
https://doi.org/10.3390/medicina60101647
AMA Style
Singh M, Negi R, Alka, Vinayagam R, Kang SG, Shukla P.
Age-Related Macular Degeneration (AMD): Pathophysiology, Drug Targeting Approaches, and Recent Developments in Nanotherapeutics. Medicina. 2024; 60(10):1647.
https://doi.org/10.3390/medicina60101647
Chicago/Turabian Style
Singh, Mahendra, Riyakshi Negi, Alka, Ramachandran Vinayagam, Sang Gu Kang, and Prashant Shukla.
2024. "Age-Related Macular Degeneration (AMD): Pathophysiology, Drug Targeting Approaches, and Recent Developments in Nanotherapeutics" Medicina 60, no. 10: 1647.
https://doi.org/10.3390/medicina60101647
APA Style
Singh, M., Negi, R., Alka, Vinayagam, R., Kang, S. G., & Shukla, P.
(2024). Age-Related Macular Degeneration (AMD): Pathophysiology, Drug Targeting Approaches, and Recent Developments in Nanotherapeutics. Medicina, 60(10), 1647.
https://doi.org/10.3390/medicina60101647